Shanghai Fudan Forward S&T (SHA:600624) decided to terminate its plan to acquire 28% of Fuhua Longzhang Health Technology (Shanghai), according to a Shanghai bourse disclosure on Saturday.
The software developer and biomedicine company's shares fell less than 2% during Monday's afternoon trade.
The decision was made because the potential transferee did not pay the deposit during the public listing period.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。